Minds and Mentors Program (MiMP)- R61

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 28, 2020

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Opioid-use DisorderMedication Assisted TreatmentSubstance Use Disorders
Interventions
BEHAVIORAL

Mindfulness based relapse prevention and peer mentoring

"Importantly, the treatment will utilize a group format. Group process can serve as a vital agent in breaking down client denial about drug abuse problems. Groups have also been shown to be suitable for treating problems commonly associated with substance abuse, including depression, isolation, and shame.~Additionally, groups intrinsically have many rewarding benefits, including reducing isolation and enabling members to witness the recovery of others. The eight-week group therapy intervention is co-led by a licensed counselor and a peer mentor for eight weeks, then followed by group sessions led by peer mentors for an additional four weeks."

Trial Locations (2)

35209

Fritz Clinic, Homewood

35235

Pathway Healthcare, LLC, Birmingham

All Listed Sponsors
collaborator

University of Alabama at Birmingham

OTHER

collaborator

Tuscaloosa Veterans Affairs Medical Center

FED

lead

University of Alabama, Tuscaloosa

OTHER

NCT04233671 - Minds and Mentors Program (MiMP)- R61 | Biotech Hunter | Biotech Hunter